$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Summary and analysis of the efficacy and clinical research of Zongatinib (Zongatinib) in patients with HER2 exon20 mutations
2026-02-01 22:25:32
Check Details
Summary and analysis of vosoritide clinical trial data and different indications, efficacy observations and safety studies
2026-02-01 22:25:32
Check Details
The main components of Methylcobalamin Injection (Rozebalamin) and its principle of promoting nerve regeneration
2026-02-01 22:25:32
Check Details
Analysis of the scope of indications and latest clinical applications of the anticancer drug cobimetinib
2026-02-01 22:25:32
Check Details
How effective is macitentan (Aoposu) in treating pulmonary arterial hypertension? Analysis of the latest clinical data
2026-02-01 22:25:32
Check Details
Which type of acute myeloid leukemia is Avonib (Tosovo) mainly used to treat?
2026-02-01 22:25:32
Check Details
Which formal channels can you buy Mitotane tablets in China?
2026-02-01 22:25:32
Check Details
Can I stop taking Pemetinib (Dabotan) at will once I start taking it?
2026-02-01 22:25:32
Check Details
Which formal channels can safely purchase Erdafitinib in China?
2026-02-01 22:25:32
Check Details
Analysis of whether Erlotinib is domestically produced or imported original drug and version differences
2026-02-01 22:25:32
Check Details
Is tofacitinib (Shangjie) available in a cream formulation and a version for external use on skin?
2026-02-01 22:25:32
Check Details
How long does it usually take to achieve the desired effect of cycloserine in conventional treatment?
2026-02-01 22:25:32
Check Details
1
2
...
2426
2427
2428
2429
2430
2431
2432
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Neurokinin Receptor Antagonists: A Non-Hormonal Approach to Menopausal Hot Flashes and Sleep Disturbances
2
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
3
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
4
FDA Approves First mRNA Flu Vaccine mFLUSIVA
5
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
6
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
7
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
8
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
9
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
10
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
11
ROS and Cancer: The Potential of Natural Antioxidants
12
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment